Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Herpes01:28

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temperature-Dependent Viral Pathogenicity: Implications for Attenuation of Viral Vaccines.

Viruses·2026
Same author

Mechanistic insights into the inhibition of drug-resistant cytomegalovirus by letermovir and ganciclovir.

British journal of pharmacology·2025
Same author

Convenient screening of the reproductive toxicity of favipiravir and antiviral drugs in <i>Caenorhabditis elegans</i>.

Heliyon·2024
Same author

Vertical mother-to-infant transmission of herpes simplex virus 2 is correlated with tropism due to mutations in viral UL13.

Journal of medical virology·2024
Same author

Preemptive intravenous human immunoglobulin G suppresses BK polyomavirus replication and spread of infection in vitro.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2023
Same author

Everolimus reduces BK polyomavirus infection by suppressing its replication and spread of infection.

Antiviral research·2022

Related Experiment Video

Updated: Jun 5, 2026

Development of an IFN-&#947; ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

[Herpes zoster and its prevention].

Hitoshi Kamiya1, Yoshizo Asano, Kimiyasu Shiraki

  • 1National Mie Hospital.

Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases
|January 14, 2011
PubMed
Summary

Herpes zoster is common, affecting one in three before age 80. The Oka varicella vaccine prevents herpes zoster and PHN in the elderly, with a review supporting its introduction in Japan.

More Related Videos

Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals
08:31

Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals

Published on: September 20, 2021

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK
07:27

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK

Published on: December 18, 2012

Related Experiment Videos

Last Updated: Jun 5, 2026

Development of an IFN-&#947; ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals
08:31

Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals

Published on: September 20, 2021

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK
07:27

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK

Published on: December 18, 2012

Area of Science:

  • Virology
  • Immunology
  • Epidemiology

Context:

  • Herpes zoster incidence in Japan is notable, particularly in individuals aged 50 and above.
  • The Oka varicella vaccine, initially for varicella, is widely used globally.
  • Previous studies suggest the vaccine boosts immunity against varicella-zoster virus in adults.

Purpose:

  • To review the link between varicella and the Oka varicella vaccine concerning herpes zoster.
  • To discuss the findings of Oxman et al. regarding vaccine efficacy in preventing herpes zoster and postherpetic neuralgia (PHN).
  • To highlight the need for introducing the Oka varicella vaccine for herpes zoster prevention in Japan.

Summary:

  • Herpes zoster incidence in Japan is 4.15/1,000 person-years, rising to 5.23-7.84/1,000 among those 50+.
  • The Oka varicella vaccine is proven to prevent herpes zoster and PHN in the elderly, as shown by Oxman et al.
  • The vaccine is approved for this purpose in the USA and Europe.

Impact:

  • The Oka varicella vaccine offers a preventative strategy against herpes zoster and PHN for the elderly population.
  • Introduction of the vaccine in Japan could significantly reduce the burden of herpes zoster.
  • This review supports the public health initiative of expanding vaccine use to older demographics.